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for Integrative Health, United StatesThe incidence of cancer in the Middle East is on the rise;
et, for many of the patients, measurable improvements in their
uality of life still remain to be demonstrated. For several can-
ers the disease is no longer fatal, however, the chronic nature
f the illness and, consequently, quality of life issues become
ery important for patients and their families, as well as for the
ractitioners who wish to deliver optimal care. It is in this regard
hat integrative oncology (i.e. the judicious combination of con-
entional and complementary therapies) may play a major role.
omplementary and Alternative Medicines (CAM) including
ind–body therapies, acupuncture, herbals, botanicals and other
ietary supplements, and a variety of lifestyle modifications, are
urrently being used during active treatment in an effort to man-
ge the disease and, especially, to alleviate treatment-related
ymptoms.
As others have pointed out, the term “CAM” is problematic,
ecause many simply view CAM as “alternative” rather than as
group of therapies and disciplines that are used in conjunction
ith conventional treatments. In response, the terms “integrative
edicine” and “Integrative Oncology” are now commonly used.
David Rosenthal has delineated the principles of integrative
ncology as combining the best of evidence-based complemen-
ary therapy and the best evidence-based conventional therapy
or each patient. Moreover, he posits that integrative oncology
hould ultimately not have to be distinguished as a separate
ntity, but be included with routine cancer care (Rosenthal, 2009)
1].
In an effort to launch a serious discussion of these issues
y cancer caregivers in the Middle East, an innovative work-
hop entitled Integrative Oncology in the Middle East: Role of
raditional Medicines in Supportive Cancer Care was offered
hrough the Middle East Cancer Consortium (MECC) and held
n June 2010 in Larnaca, Cyprus. Support was provided by a
umber of organizations including the National Cancer Institute,
he Institute for Integrative Health and the Symington Founda-
ion. Over 60 oncologists, nurses and social workers, as well as
ntegrative medicine physicians and scientists, mostly from the
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Open access under CC BY-NC-ND licountries that are members of MECC (Cyprus, Egypt, Israel,
ordan, Palestinian Authority and Turkey), and leading indi-
iduals from Europe, India and the United States, attended the
orum. A number of the key presentations were published as full
anuscripts in EUJIM over the past several months [2–5]. In this
ssue of EUJIM, we complete the collection from that workshop
y providing short summaries of the noteworthy presentations
n the form of extended abstracts.
With the increase in the success of various cancer treatments,
he number of cancer survivors has also increased, and with
hat the need for supportive cancer care. We look forward to
urther research outcomes in Integrative Oncology in the Mid-
le East and around the world to establish best practices for
nabling patients to tolerate therapy and to treat therapy-related
ymptoms.
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